Key Drivers
- Stabilizing cashflow
- Earnings volatility
- Intangible concentration
AIAI Summary
ICU Medical has shifted from a growth roll‑up to an execution story where margin expansion and deleveraging—contingent on FDA/warning‑letter resolution, tariff mitigation, and realization of integration synergies—are the primary drivers of value, so investors should pivot from top‑line bets to monitoring those specific milestones (regulatory approvals, tariff/source changes, and consistent free‑cash‑flow conversion) as the make‑or‑break catalysts for upside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Stabilizing cashflow
- •Earnings volatility
- •Intangible concentration
ICU Medical generates healthy cash flow and gross margins but faces volatile profitability, large intangible asset exposure, and stretched valuation multiples despite modest operating earnings.
Price Behavior
Key Price Behavior Insights:
- •Short-term downtrend
- •Trading under SMA
- •Support at $125
Over the last month the stock fell roughly 20% to $125.36 and is trading well below its last-month SMA (~$137.97), indicating bearish momentum with immediate support near $125.29 and resistance around $137.97 and $142.46–$150.82 that must be reclaimed to flip the outlook.
~20% decline over three–four weeks indicating pronounced short-term selling pressure
Sentiment & News
Key News Insights:
- •Institutional accumulation
- •Investor outreach
- •No operational change
ICU Medical saw heightened investor activity and outreach as Victory Capital added a material stake while the company scheduled investor conferences, signaling increased market engagement without operational news.
The developments should modestly improve market sentiment and trading interest in ICUI but do not alter the company's fundamentals
Similar Companies in Healthcare
Other companies in the same sector with AI ratings